Senior agrees to extend Advent takeover offer deadline amid talks
27th Mar 2026 09:26
(Alliance News) - Senior PLC on Friday said it has extended the deadline for a revised takeover offer from Advent International LP. Read More
(Alliance News) - Senior PLC on Friday said it has extended the deadline for a revised takeover offer from Advent International LP. Read More
Avacta Group PLC - London-based biopharmaceutical company developing a tumour-activated oncology delivery platform - Raises GBP10 million from a placing of and subscription to 15.9 million new shares at 63 pence each. The new shares represent 3.6% of Avacta's total prior to the issuance. Two non-executive directors, Richard Hughes and David Bryant, contribute a total of GBP550,000 to the raise. The share offer is run by Zeus Capital as broker and bookrunner. Zeus will receive warrants over 4.4 million new shares at the same 63p price, exercisable over five years. The raise is in line with the plan announced after the London market close on Thursday. The fresh cash will be used to progress Avacta's research and development programmes into early in the first quarter of 2027, providing enough cash to get to initial data from a phase 1a trial of AVA6103, its second clinical program. AVA6103, a peptide drug conjugate. Read More
(Alliance News) - Lloyds Banking Group PLC has paid out compensation after nearly half a million people were impacted by an IT glitch exposing the personal data of customers earlier this month. Read More
(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 edging higher despite continued uncertainty regarding Iran peace talks and muted sentiment across European markets. Read More
(Alliance News) - BASF SE on Friday said it has reduced its shareholding in Harbour Energy PLC, acquired as part of the Wintershall Dea deal, selling a 6.5% stake to cut its holding to 35% from 41.5%. Read More
(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepirovirsen. Read More
(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozorakimab. Read More
Metlen Energy & Metals PLC - Athens-based energy and metallurgy company - Says external auditors PricewaterhouseCoopers LLP and PricewaterhouseCoopers SA request more time to complete work on its 2025 financial statement, Metlen's first as a dual-listed entity in London and Athens. Metlen will now release of its annual results on April 9 after a nine-day delay. It confirms guidance of earnings before interest, tax, depreciation and amortisation of around GBP750 million. Read More
(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More
(Alliance News) - Food delivery company Just Eat, funeral firm Dignity and motor platform Autotrader Group PLC are among five firms under investigation by the UK's competition watchdog as part of its crackdown on fake and misleading online reviews. Read More
(Alliance News) - UK retail sales volumes fell in February after a strong start to the year, though sales remained higher over the three months, official data showed Friday. Read More
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Hires Heikki Jouttijarvi as chief technical officer, saying he has decades of experience in biopharma manufacturing, supply chain management and commercial operations. Chief Executive Officer Juho Jalkanen says: "His wealth of experience with commercial operations, manufacturing and supply chain management with late-stage and approved drugs is incredibly valuable for us as we progress with bexmarilimab to the announced phase IIb trial in higher-risk myelodysplastic syndromes". Bexmarilimab is an investigational immunotherapy designed to overcome resistance to existing treatments, among others. Myelodysplastic syndromes are a type of blood cancer. Read More
(Alliance News) - Stocks in London are set to open higher on Friday, as easing tensions in the Middle East after fresh US-Iran developments offer some relief to markets. Read More
(Alliance News) - Anheuser-Busch InBev NV announced on Friday its Chair Martin Barrington will retire at the end of next month after seven years in charge. Read More
Pan African Resources PLC - Rosebank-headquartered gold producer - Says its shareholders have approved the share capital reduction plan. The general meeting to vote on this plan was held on Thursday. The share capital reduction involves the cancellation of the Pan African's share premium account, and the "cancellation and extinguishment" of certain shares in its capital. Pan African expects the capital reduction to be effective on April 29. It expects the court hearing to confirm the capital reduction on April 28. Read More